Bloomberg Markets
Bloomberg Intelligence's Sam Fazeli discusses AbbVie's $10.9 billion acquisition of Apogee Therapeutics. The deal enhances AbbVie's presence in dermatology by adding treatments for atopic dermatitis, commonly known as eczema, to its portfolio. He speaks on "Bloomberg Open Interest." (Source: Bloomberg)
CNBC Finance
Lucid Group is cutting its U.S. workforce by 18% as part of a cost-savings plan. It also said COO Marc Winterhoff is departing effective immediately.
Yahoo Finance
Yahoo Finance
Bloomberg Markets
Tarek Robbiati, CFO of data storage company Everpure, said that the increased capex spend on AI is 'not temporary' even if the industry supply and demand equation rebalances and more AI capacity becomes available. Robbiati said that while the AI market is expected to revert to a mean, it will not happen quickly and it may not go back to the same level. (Source: Bloomberg)
Yahoo Finance